Timothy Schmid insider trades: Johnson & Johnson (JNJ) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Timothy reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | JNJ | ↓ Sell | 33,597 | $274.74 | $9.2M | Direct | Sep 4, 2026 (2d) |
| Feb 20, 2026 | JNJ | ↓ Sell | 1,322 | $245.66 | $325K | Direct | Feb 23, 2026 (3d) |
| Feb 18, 2026 | JNJ | ↓ Sell | 22,623 | $244.33 | $5.5M | Direct | Feb 18, 2026 (0d) |
| Feb 18, 2025 | JNJ | ↓ Sell | 403 | $156.15 | $63K | Direct | Feb 18, 2025 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other JNJ insiders
Open-market trades in the last 12 months
About Timothy Schmid's insider trades
Timothy Schmid is EVP, WW Chair, MedTech at Johnson & Johnson (JNJ). Since Feb 18, 2025, Timothy has reported no open-market purchases and 4 sales worth $15.1M on SEC Form 4. In the last 12 months: 3 sales ($15.1M).
Their filings also include option exercises (8 filings), shares withheld for taxes (7 filings), grants and awards (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every JNJ insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.